Reprint

Coffee and Caffeine Consumption for Human Health

Edited by
October 2022
364 pages
  • ISBN978-3-0365-5499-0 (Hardback)
  • ISBN978-3-0365-5500-3 (PDF)

This book is a reprint of the Special Issue Coffee and Caffeine Consumption for Human Health that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

Caffeine is present in coffee and many other beverages and is the most widely used central nervous system stimulant.  Coffee drinking or caffeine supplementation may have a role in preventing cardiometabolic and endocrine disease, neuroinflammation, cancer, and even all-cause mortality. Other aspects are either less known or controversial, including the effects on the brain–gut axis, neurodevelopment, behavior, pain, muscle–skeletal health, skin or sexual function. Studies focusing on special populations (neonates, children, adolescents, athletes, elderly, pregnant and nonpregnant women), or interactions with other drugs and foods, are relatively scarce but of obvious interest. Other compounds present in coffee and other caffeinated food stuffs may affect caffeine´s physiological effects with a tremendous impact on health. This Special Issue, which contains twenty-one manuscripts, has focused on some of these varied topics, providing further evidence of the multiple health benefits that coffee/caffeine intake may exert in humans, at least in specific populations (with a particular genetic profile or suffering from specific diseases). However, the specific effects in the different organs and systems, as well as the mechanisms involved are not yet clear. Furthermore, within the current context aiming to sustainable development, the coffee plant Coffee sp. and its so-far relatively neglected by-products are expected to become soon a source of ingredients for new functional foods whose properties will need to be precisely determined. We hope the readers of this Special Issue will find inspiration for new studies on the topic.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
caffeine intake; Switzerland; national nutrition survey; coffee; tea; soft drinks; ballistic exercise; upper limbs; resistance exercise; ergogenic substances; sport performance; Adenosine receptors; genetic variants; coffee; dyslipidemia; Korean Genome and Epidemiology Study (KoGES); coffee drinking; TRIB1; rs17321515; CHD; Taiwan Biobank; coffee consumption; c-reactive protein; cross-sectional studies; systematic review and meta-analysis; Red Bull energy drink; caffeine; taurine; hypoxia; ventilation/perfusion distribution; multiple inert gas elimination technique; piglets; coffee; phytochemicals; caffeine; diabetes; DNA damage; antioxidant; Nrf2; microbiota; caffeine; Parkinson’s disease; risk; progression; meta-analysis; coffee consumption; type 2 diabetes; prediabetes; genome-wide association analysis (GWAS); single nucleotide polymorphism (SNP); caffeine; subjective; expectancy; instrument; validation; Brazilian; Portuguese; migraine; headache; caffeine; coffee; trigger; withdrawal headache; adenosine; vasoconstriction; cerebral blood flow; coffee; caffeine; multiple sclerosis; fatigue; caffeine; coffee; physical activity; siting time; inflammation; body fat; caffeine; Saccharomyces cerevisiae; irradiation; DNA damage; TOR; signaling; lifespan; coffee; hepatitis C; HIV; neurocognitive disorders; urine caffeine metabolites; urine flow rate; caffeine; neurological and psychiatric disorders; sleep disorder; stroke; dementia; depression; sex differences; Eurycoma longifolia; Tongkat ali; toxicity; infused coffee; herbal additives; caffeine; coffee; dietary supplements; hepatic steatosis; non-alcoholic fatty liver disease; brain–gut axis; caffeine; coffee; coffee by-products; dietary fiber; enteric; gastrointestinal; melanoidins; mucosa; myenteric; trait energy; trait fatigue; caffeine; moods; cognitive tasks; psychomotor tasks; n/a